Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Collaboration to develop a Granzyme B-targeted agent for PET imaging applications in inflammation and cancer indications
Source: itnonline.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Granzymeb Targeted. Real-time updates on events, politics, business and more.